Congress gains leverage over global anti-doping body through conditional funding
S. 233 — Restoring Confidence in the World Anti-Doping Agency Act of 2025 · Filed by Marsha Blackburn (R-TN) · 6 cosponsors · Introduced Jan 23, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill gives the U.S. Office of National Drug Control Policy (ONDCP) the power to annually assess whether the World Anti-Doping Agency (WADA) has fair governance, independent decision-making, and adequate U.S. representation. If WADA fails these tests, the ONDCP can withhold U.S. membership dues (up to the full amount), must report to Congress on barriers to U.S. participation, and must submit spending plans before paying any dues. The bill essentially makes U.S. funding conditional on WADA meeting specific governance and representation standards.
Why we flagged it
The bill's core mechanism is conditional funding tied to governance standards and mandatory congressional reporting. It is fundamentally about U.S. leverage over WADA and increased transparency to Congress, not about anti-doping policy itself.
What the text implies
- Withholding dues could fragment global anti-doping enforcement if other nations follow suit or if WADA loses operational capacity, potentially harming clean athletes worldwide.
- The bill does not define what constitutes 'fair representation' or 'credible governance'—these are subjective standards that ONDCP will apply annually, creating potential for politicization of anti-doping policy.
The full analysis lists 4 implications of this text.
Who it affects
The bill strengthens U.S. leverage over an international anti-doping body and increases congressional oversight of how U.S.